Company intelligence / Profile preview

Vaginal Biome Science

Portland, Oregon, United States

Ownership: Private
Development stage: Other

Overview

Vaginal Biome Science is a private, active company founded in 2021, pioneering microbiome-driven diagnostics and therapeutics for vaginal and gynecological health. The company has several ongoing and completed clinical trials evaluating proprietary diagnostics and the Flourish HEC Vaginal Care System in bacterial vaginosis, recurrent UTIs, and menopausal microbiome health, with exploratory and pilot outcomes in microbiome modulation, recurrence reduction, and patient symptom management.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Live biotherapeutic product therapyMicrobial therapyDeviceDiagnostics
Industry: Biotech

Drug pipeline

1 asset

Vaginal Biome Science probiotic vaginal suppository

Preclinical

Beyond the preview

Go deeper on Vaginal Biome Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal Biome Science.

Explore the full profile